{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:56:10Z","timestamp":1793350570407,"version":"4.5.0"},"reference-count":186,"publisher":"Elsevier","isbn-type":[{"value":"9780443235306","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.pmbts.2024.04.003","type":"book-chapter","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T12:17:46Z","timestamp":1714220266000},"page":"163-234","source":"Crossref","is-referenced-by-count":16,"title":["Daptomycin: Mechanism of action, mechanisms of resistance, synthesis and structure-activity relationships"],"prefix":"10.1016","author":[{"given":"Scott D.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7164\/antibiotics.40.761","article-title":"A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation","volume":"40","author":"Debono","year":"1987","journal-title":"J Antibiot"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02097208","article-title":"In vitro activity of LY146032 (Daptomycin), a new peptolide","volume":"6","author":"Ehlert","year":"1987","journal-title":"Eur J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02097209","article-title":"In vitro activity of LY146032 (Daptomycin) against selected aerobic bacteria","volume":"6","author":"Jorgensen","year":"1987","journal-title":"Eur J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF02097211","article-title":"Comparative in vitro activity of IY146032 (daptomycin), a new lipopeptide antimicrobial","volume":"6","author":"Hodinka","year":"1987","journal-title":"Eur J\u00a0Clin Microbiol"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/13543784.8.8.1223","article-title":"Daptomycin: a novel agent for Gram-positive infections","volume":"8","author":"Tally","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0168-1656(88)90040-5","article-title":"The formation of daptomycin by supplying decanoic acid to Streptomyces roseosporus cultures producing the antibiotic complex A21978C","volume":"7","author":"Huber","year":"1988","journal-title":"J Biotechnol"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/AAC.36.2.318","article-title":"Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers","volume":"36","author":"Woodworth","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib8","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/AAC.44.11.2948-2953.2000","article-title":"Once-daily dosing in dogs optimizes daptomycin safety","volume":"44","author":"Oleson","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/bs.pmbts.2024.04.003_bib9","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1086\/647938","article-title":"Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD","volume":"50","author":"Eisenstein","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/pathogens13010088","article-title":"Antibiotic resistance to molecules commonly prescribed for the treatment of antibiotic-resistant Gram-positive pathogens: what is relevant for the clinician?","volume":"13","author":"Tebano","year":"2024","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.04.003_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10295-017-1999-8","article-title":"Synthetic biology, genome mining, and combinatorial biosynthesis of NRPS-derived antibiotics: a perspective","volume":"45","author":"Baltz","year":"2018","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/sb3000673","article-title":"Combinatorial biosynthesis of cyclic lipopeptide antibiotics: a model for synthetic biology to accelerate the evolution of secondary metabolite biosynthetic pathways","volume":"3","author":"Baltz","year":"2014","journal-title":"ACS Synth Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/antibiotics9010017","article-title":"More than a pore: a current perspective on the in vivo mode of action of the lipopeptide antibiotic daptomycin","volume":"9","author":"Gray","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00232-021-00175-0","article-title":"The antibiotic peptide daptomycin functions by reorganizing the membrane","volume":"254","author":"Pokorny","year":"2021","journal-title":"J Membr Biol"},{"issue":"24","key":"10.1016\/bs.pmbts.2024.04.003_bib15","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1016\/j.bmc.2016.05.052","article-title":"The action mechanism of daptomycin","volume":"24","author":"Taylor","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"22","key":"10.1016\/bs.pmbts.2024.04.003_bib16","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1021\/acs.jmedchem.0c00780","article-title":"Structure\u2013activity relationships of daptomycin lipopeptides","volume":"63","author":"Karas","year":"2020","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12948","article-title":"Mechanisms of drug resistance: daptomycin resistance","volume":"1354","author":"Tran","year":"2015","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/antibiotics10030263","article-title":"Impact on antibiotic resistance, therapeutic success, and control of side effects in therapeutic drug monitoring (TDM) of daptomycin: a scoping review","volume":"10","author":"Osorio","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib19","doi-asserted-by":"crossref","first-page":"1035574","DOI":"10.3389\/fmolb.2022.1035574","article-title":"Bacterial cell membranes and their role in daptomycin resistance: a review","volume":"9","author":"Nguyen","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"Pt 5","key":"10.1016\/bs.pmbts.2024.04.003_bib20","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1099\/mic.0.27757-0","article-title":"Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry","volume":"151","author":"Miao","year":"2005","journal-title":"Microbiology (Read)"},{"issue":"36","key":"10.1016\/bs.pmbts.2024.04.003_bib21","doi-asserted-by":"crossref","first-page":"27501","DOI":"10.1074\/jbc.R110.128181","article-title":"Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery","volume":"285","author":"Robbel","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.04.003_bib22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1365-2958.2006.05305.x","article-title":"A glutamic acid 3-methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus","volume":"61","author":"Nguyen","year":"2006","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/AAC.01307-09","article-title":"Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties","volume":"54","author":"Nguyen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jac\/20.2.213","article-title":"The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci","volume":"20","author":"Andrew","year":"1987","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.30.4.532","article-title":"In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic","volume":"30","author":"Eliopoulos","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.27.3.357","article-title":"In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic","volume":"27","author":"Eliopoulos","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.04.003_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1039\/C9MD00126C","article-title":"The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry","volume":"10","author":"Wood","year":"2019","journal-title":"Medchemcomm"},{"issue":"51","key":"10.1016\/bs.pmbts.2024.04.003_bib28","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1021\/ja045455t","article-title":"Synthesis and derivatization of daptomycin: a chemoenzymatic route to acidic lipopeptide antibiotics","volume":"126","author":"Gr\u00fcnewald","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.04.003_bib29","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/acsmedchemlett.0c00175","article-title":"Establishing the structure\u2013activity relationship of daptomycin","volume":"11","author":"Chow","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib30","doi-asserted-by":"crossref","first-page":"e23094","DOI":"10.1002\/bip.23094","article-title":"An entirely fmoc solid phase approach to the synthesis of daptomycin analogs","volume":"111","author":"Barnawi","year":"2019","journal-title":"Peptide Sci"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib31","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/jps.22608","article-title":"Estimated pKa values for specific amino acid residues in daptomycin","volume":"100","author":"Qiu","year":"2011","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.04.003_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1015927330908","article-title":"Kinetics of the aspartyl transpeptidation of daptomycin, a novel lipopeptide antibiotic","volume":"6","author":"Kirsch","year":"1989","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.04.003_bib33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.chembiol.2004.04.020","article-title":"Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin","volume":"11","author":"Jung","year":"2004","journal-title":"Chem Biol"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib34","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1021\/acsinfecdis.1c00316","article-title":"Binding studies reveal phospholipid specificity and its role in the calcium-dependent mechanism of action of daptomycin","volume":"7","author":"Kotsogianni","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"13","key":"10.1016\/bs.pmbts.2024.04.003_bib35","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1039\/b402722a","article-title":"NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin","volume":"2","author":"Ball","year":"2004","journal-title":"Org Biomol Chem"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib36","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.bbamem.2016.05.020","article-title":"Two successive calcium-dependent transitions mediate membrane binding and oligomerization of daptomycin and the related antibiotic A54145","volume":"1858","author":"Taylor","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bpj.2017.05.025","article-title":"Molecular state of the membrane-active antibiotic daptomycin","volume":"113","author":"Lee","year":"2017","journal-title":"Biophys J"},{"issue":"39","key":"10.1016\/bs.pmbts.2024.04.003_bib38","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1021\/acs.jpcb.8b07503","article-title":"A quantitative model of daptomycin binding to lipid bilayers","volume":"122","author":"Pokorny","year":"2018","journal-title":"J Phys Chem B"},{"issue":"2-3","key":"10.1016\/bs.pmbts.2024.04.003_bib39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/bip.20238","article-title":"A well-defined amphipathic conformation for the calcium-free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution","volume":"80","author":"Rotondi","year":"2005","journal-title":"Biopolymers"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00249-007-0227-2","article-title":"Effect of divalent cations on the structure of the antibiotic daptomycin","volume":"37","author":"Ho","year":"2008","journal-title":"Eur Biophys J"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.04.003_bib41","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.bbamem.2007.08.034","article-title":"NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles","volume":"1768","author":"Scott","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"10.1016\/bs.pmbts.2024.04.003_bib42","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1021\/bi00413a009","article-title":"Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY 146032 and phospholipid membranes","volume":"27","author":"Lakey","year":"1988","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.chemphyslip.2008.04.004","article-title":"Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes","volume":"154","author":"Jung","year":"2008","journal-title":"Chem Phys Lipids"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/jps.23859","article-title":"Evaluation of lipopeptide (daptomycin) aggregation using fluorescence, light scattering, and nuclear magnetic resonance spectroscopy","volume":"103","author":"Qiu","year":"2014","journal-title":"J Pharm Sci"},{"issue":"14","key":"10.1016\/bs.pmbts.2024.04.003_bib45","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/cphc.201600308","article-title":"Self-assembly of the cyclic lipopeptide daptomycin: spherical micelle formation does not depend on the presence of calcium chloride","volume":"17","author":"Kirkham","year":"2016","journal-title":"ChemPhysChem"},{"issue":"30","key":"10.1016\/bs.pmbts.2024.04.003_bib46","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1021\/jacs.2c03949","article-title":"Time-resolved atomistic imaging and statistical analysis of daptomycin oligomers with and without calcium ions","volume":"144","author":"Nakamuro","year":"2022","journal-title":"J Am Chem Soc"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bbamem.2006.02.009","article-title":"Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides","volume":"1758","author":"Straus","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib48","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.bbamem.2011.01.001","article-title":"Oligomerization of daptomycin on membranes","volume":"1808","author":"Muraih","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib49","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbapap.2017.07.020","article-title":"On the quest for the elusive mechanism of action of daptomycin: binding, fusion, and oligomerization","volume":"1865","author":"Zhang","year":"2017","journal-title":"Biochim Biophys Acta\u2014Proteins Proteom"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-3084(78)90052-X","article-title":"Lipids of the streptomycetes structural investigation and biological interrelation: a review","volume":"21","author":"Batrakov","year":"1978","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.02005-12","article-title":"The target of daptomycin is absent from Escherichia coli and other Gram-negative pathogens","volume":"57","author":"Randall","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib52","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/acsinfecdis.2c00313","article-title":"A54145 factor D is not less susceptible to inhibition by lung surfactant than daptomycin","volume":"8","author":"Moreira","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib53","doi-asserted-by":"crossref","first-page":"16194","DOI":"10.1038\/nmicrobiol.2016.194","article-title":"Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids","volume":"2","author":"Pader","year":"2016","journal-title":"Nat Microbiol"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib54","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1099\/mic.0.000529","article-title":"Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids","volume":"163","author":"Ledger","year":"2017","journal-title":"Microbiology (Read)"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib55","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1128\/AAC.01819-10","article-title":"Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis","volume":"55","author":"Hachmann","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.04.003_bib56","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib57","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1128\/AAC.01329-08","article-title":"Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin","volume":"53","author":"Hachmann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"17","key":"10.1016\/bs.pmbts.2024.04.003_bib58","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins","volume":"194","author":"Pogliano","year":"2012","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib59","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1021\/acsinfecdis.2c00262","article-title":"Establishing the structure-activity relationship between phosphatidylglycerol and daptomycin","volume":"8","author":"Moreira","year":"2022","journal-title":"ACS Infect Dis"},{"issue":"38","key":"10.1016\/bs.pmbts.2024.04.003_bib60","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1021\/acs.biochem.8b00818","article-title":"Comparison of the effects of daptomycin on bacterial and model membranes","volume":"57","author":"Lee","year":"2018","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202114858","article-title":"The chiral target of daptomycin is the 2r,2\u2019s stereoisomer of phosphatidylglycerol","volume":"61","author":"Moreira","year":"2022","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib62","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/AAC.01040-08","article-title":"The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate","volume":"53","author":"Schneider","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib63","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.00170-11","article-title":"Mechanism of action and limited cross-resistance of new lipopeptide MX-2401","volume":"55","author":"Rubinchik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib64","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1128\/AAC.00443-11","article-title":"Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate","volume":"55","author":"Hashizume","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/antibiotics8030123","article-title":"Anti-mycoplasma activity of daptomycin and its use for mycoplasma elimination in cell cultures of rickettsiae","volume":"8","author":"Tantibhedhyangkul","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib66","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1128\/AAC.00770-12","article-title":"Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilis","volume":"56","author":"Wolf","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib67","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.34.6.1220","article-title":"Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)","volume":"34","author":"Canepari","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/31.2.227","article-title":"The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis","volume":"31","author":"Boaretti","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib69","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-020-15257-1","article-title":"Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids","volume":"11","author":"Grein","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib70","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1128\/AAC.39.9.2068","article-title":"Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae","volume":"39","author":"Boaretti","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib71","first-page":"305","article-title":"Purification of daptomycin binding proteins (DBPs) from the membrane of Enterococcus hirae","volume":"23","author":"Boaretti","year":"2000","journal-title":"N Microbiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib72","doi-asserted-by":"crossref","first-page":"e10023","DOI":"10.1002\/ntls.10023","article-title":"Daptomycin exerts bactericidal effect through induction of excessive ROS production and blocking the function of stress response protein Usp2","volume":"1","author":"Po","year":"2021","journal-title":"Nat Sci"},{"issue":"18","key":"10.1016\/bs.pmbts.2024.04.003_bib73","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1128\/JB.187.18.6265-6272.2005","article-title":"Differential roles of the universal stress proteins of Escherichia coli in oxidative stress resistance, adhesion, and motility","volume":"187","author":"Nachin","year":"2005","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib74","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijmm.2014.11.008","article-title":"Acinetobacter baumannii universal stress protein A plays a pivotal role in stress response and is essential for pneumonia and sepsis pathogenesis","volume":"305","author":"Elhosseiny","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-micro-091213-112949","article-title":"Lipoteichoic acid synthesis and function in Gram-positive bacteria","volume":"68","author":"Percy","year":"2014","journal-title":"Annu Rev Microbiol"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib76","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1128\/AAC.47.8.2682-2684.2003","article-title":"In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis","volume":"47","author":"Laganas","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"33","key":"10.1016\/bs.pmbts.2024.04.003_bib77","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1021\/bi500779g","article-title":"Interaction of daptomycin with lipid bilayers: a lipid extracting effect","volume":"53","author":"Chen","year":"2014","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.04.003_bib78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00249-020-01445-w","article-title":"Model lipid systems and their use to evaluate the phase state of biomembranes, their mechanical properties and the effect of non-conventional antibiotics: the case of daptomycin","volume":"49","author":"Balleza","year":"2020","journal-title":"Eur Biophys J"},{"issue":"2-3","key":"10.1016\/bs.pmbts.2024.04.003_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00232-019-00067-4","article-title":"Role of lipid composition, physicochemical interactions, and membrane mechanics in the molecular actions of microbial cyclic lipopeptides","volume":"252","author":"Balleza","year":"2019","journal-title":"J Membr Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tim.2016.12.008","article-title":"The role of reactive oxygen species in antibiotic-mediated killing of bacteria","volume":"25","author":"Van Acker","year":"2017","journal-title":"Trends Microbiol"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib81","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1128\/AAC.00754-12","article-title":"Inhibitors of reactive oxygen species accumulation delay and\/or reduce the lethality of several antistaphylococcal agents","volume":"56","author":"Liu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.04.003_bib82","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/antibiotics10050511","article-title":"Catalase protects biofilm of Staphylococcus aureus against daptomycin activity","volume":"10","author":"El Haj","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.04.003_bib83","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/AAC.31.7.1093","article-title":"Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032","volume":"31","author":"Allen","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib84","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1128\/AAC.35.11.2282","article-title":"Daptomycin disrupts membrane potential in growing Staphylococcus aureus","volume":"35","author":"Alborn","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib85","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.04.003_bib86","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jac\/dkn321","article-title":"Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus","volume":"62","author":"Hobbs","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib87","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamem.2011.10.027","article-title":"Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation","volume":"1818","author":"Muraih","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"47","key":"10.1016\/bs.pmbts.2024.04.003_bib88","doi-asserted-by":"crossref","first-page":"13669","DOI":"10.1021\/acs.langmuir.7b01841","article-title":"Daptomycin\u2013phosphatidylglycerol domains in lipid membranes","volume":"33","author":"Kreutzberger","year":"2017","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib89","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.bbamem.2014.05.014","article-title":"Daptomycin forms cation- and size-selective pores in model membranes","volume":"1838","author":"Zhang","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib90","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/acsinfecdis.6b00152","article-title":"Daptomycin leakage is selective","volume":"2","author":"Zhang","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib91","unstructured":"Taylor R. The lipopeptide antibiotic daptomycin: its interaction with calcium and membranes and the effects of membrane lipid composition on its activity. Doctoral Thesis. University of Waterloo. https:\/\/uwspace.uwaterloo.ca\/handle\/10012\/12919; 2018 Accessed 12.02.24."},{"key":"10.1016\/bs.pmbts.2024.04.003_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.chemphyslip.2018.09.015","article-title":"Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation","volume":"216","author":"Beriashvili","year":"2018","journal-title":"Chem Phys Lipids"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib93","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/acsinfecdis.7b00138","article-title":"Daptomycin pore formation is restricted by lipid acyl chain composition","volume":"3","author":"Taylor","year":"2017","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01589-18","article-title":"Daptomycin pore formation and stoichiometry depend on membrane potential of target membrane","volume":"63","author":"Seydlov\u00e1","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib95","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1038\/s41467-020-19710-z","article-title":"High-speed atomic force microscopy highlights new molecular mechanism of daptomycin action","volume":"11","author":"Zuttion","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib96","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1128\/AAC.02955-14","article-title":"Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16","volume":"58","author":"Mensa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"45","key":"10.1016\/bs.pmbts.2024.04.003_bib97","doi-asserted-by":"crossref","first-page":"E7077","DOI":"10.1073\/pnas.1611173113","article-title":"Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains","volume":"113","author":"M\u00fcller","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib98","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.01410-07","article-title":"Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus","volume":"52","author":"Cotroneo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1574-6968.1990.tb04238.x","article-title":"Inhibition of peptidoglycan biosynthesis in Bacillus megaterium by daptomycin","volume":"57","author":"Mengin-Lecreulx","year":"1990","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib100","doi-asserted-by":"crossref","first-page":"8609218","DOI":"10.1155\/2019\/8609218","article-title":"Multifunctional pharmaceutical effects of the antibiotic daptomycin","volume":"2019","author":"Ye","year":"2019","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib101","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/AAC.01046-08","article-title":"Daptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses","volume":"53","author":"Wecke","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib102","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1099\/00222615-30-1-45","article-title":"Scanning electronmicroscopy of Staphylococcus aureus and Enterococcus faecalis exposed to daptomycin","volume":"30","author":"Wale","year":"1989","journal-title":"J Med Microbiol"},{"issue":"22","key":"10.1016\/bs.pmbts.2024.04.003_bib103","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1021\/acs.jpcb.1c02047","article-title":"Daptomycin-induced lipid phases on model lipid bilayers: effect of lipid type and of lipid leaflet order on membrane permeability","volume":"125","author":"Howe","year":"2021","journal-title":"J Phys Chem B"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib104","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbalip.2016.11.013","article-title":"Bacterial aminoacyl phospholipids\u2014biosynthesis and role in basic cellular processes and pathogenicity","volume":"1862","author":"Slavetinsky","year":"2017","journal-title":"Biochim Biophys Acta\u2014Mol Cell Biol Lipids"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.193.9.1067","article-title":"Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine","volume":"193","author":"Peschel","year":"2001","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib106","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/AAC.00191-10","article-title":"Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance","volume":"54","author":"Kilelee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib107","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.bbamem.2014.04.018","article-title":"Lysylated phospholipids stabilize models of bacterial lipid bilayers and protect against antimicrobial peptides","volume":"1838","author":"Cox","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib108","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/21505594.2015.1011532","article-title":"Impact of daptomycin resistance on Staphylococcus aureus virulence","volume":"6","author":"Cameron","year":"2015","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib109","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.00429-10","article-title":"Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus","volume":"55","author":"Rubio","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib110","doi-asserted-by":"crossref","first-page":"e66376","DOI":"10.7554\/eLife.66376","article-title":"Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF","volume":"11","author":"Slavetinsky","year":"2022","journal-title":"Elife"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib111","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.02182-12","article-title":"Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus","volume":"57","author":"Mishra","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175886","article-title":"Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalis","volume":"12","author":"Rashid","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib113","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/AAC.00122-10","article-title":"Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms","volume":"54","author":"Yang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib114","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01659-18","article-title":"Gain-of-function mutations in the phospholipid flippase MprF confer specific daptomycin resistance","volume":"9","author":"Ernst","year":"2018","journal-title":"mBio"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib115","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1128\/AAC.00744-16","article-title":"Binding of daptomycin to anionic lipid vesicles is reduced in the presence of lysyl-phosphatidylglycerol","volume":"60","author":"Khatib","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"47","key":"10.1016\/bs.pmbts.2024.04.003_bib116","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1039\/D2OB01384C","article-title":"The impact of lysyl-phosphatidylglycerol on the interaction of daptomycin with model membranes","volume":"20","author":"Moreira","year":"2022","journal-title":"Org Biomol Chem"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.04.003_bib117","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1128\/AAC.00370-12","article-title":"Alanyl-phosphatidylglycerol and lysyl-phosphatidylglycerol are translocated by the same MprF flippases and have similar capacities to protect against the antibiotic daptomycin in Staphylococcus aureus","volume":"56","author":"Slavetinsky","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038458","article-title":"Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000660","article-title":"The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion","volume":"5","author":"Ernst","year":"2009","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib120","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41467-021-23248-z","article-title":"Phospholipid translocation captured in a bifunctional membrane protein MprF","volume":"12","author":"Song","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028316","article-title":"Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus","volume":"7","author":"Peleg","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib122","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.1812066116","article-title":"Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation","volume":"116","author":"Jiang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib123","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41467-022-29717-3","article-title":"Human serum triggers antibiotic tolerance in Staphylococcus aureus","volume":"13","author":"Ledger","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib124","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic basis for in vivo daptomycin resistance in enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2024.04.003_bib125","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1128\/AAC.00207-11","article-title":"Genetic basis for daptomycin resistance in enterococci","volume":"55","author":"Palmer","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib126","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00281-13","article-title":"Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids","volume":"4","author":"Tran","year":"2013","journal-title":"mBio"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib127","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/AAC.01743-12","article-title":"Biochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci","volume":"57","author":"Davlieva","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib128","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/AAC.02686-14","article-title":"Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs","volume":"58","author":"Diaz","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib129","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1128\/AAC.01318-12","article-title":"Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium","volume":"56","author":"Humphries","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib130","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/jac\/dkt117","article-title":"Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome","volume":"68","author":"Kelesidis","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/AAC.01454-12","article-title":"Whole-genome analysis of a daptomycin-susceptible Enterococcus faecium strain and its daptomycin-resistant variant arising during therapy","volume":"57","author":"Tran","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib132","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1093\/gbe\/evw241","article-title":"Comparative genome analysis of the daptomycin-resistant Streptococcus anginosus strain J4206 associated with breakthrough bacteremia","volume":"8","author":"Rahman","year":"2016","journal-title":"Genome Biol Evol"},{"issue":"17","key":"10.1016\/bs.pmbts.2024.04.003_bib133","doi-asserted-by":"crossref","first-page":"11584","DOI":"10.1074\/jbc.M114.554444","article-title":"Cardiolipin prevents membrane translocation and permeabilization by daptomycin","volume":"289","author":"Zhang","year":"2014","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/bs.pmbts.2024.04.003_bib134","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01531-18","article-title":"Mutations in cdsA and pgsA correlate with daptomycin resistance in Streptococcus mitis and S. oralis","volume":"63","author":"Tran","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"10.1016\/bs.pmbts.2024.04.003_bib135","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1128\/JB.00310-06","article-title":"Regulation of LiaRS-dependent gene expression in Bacillus subtilis: identification of inhibitor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system","volume":"188","author":"Jordan","year":"2006","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib136","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/mmi.12130","article-title":"Stoichiometry and perturbation studies of the LiaFSR system of Bacillus subtilis","volume":"87","author":"Schrecke","year":"2013","journal-title":"Mol Microbiol"},{"issue":"52","key":"10.1016\/bs.pmbts.2024.04.003_bib137","doi-asserted-by":"crossref","first-page":"26925","DOI":"10.1073\/pnas.1916037116","article-title":"Antimicrobial sensing coupled with cell membrane remodeling mediates antibiotic resistance and virulence in Enterococcus faecalis","volume":"116","author":"Khan","year":"2019","journal-title":"Proc Natl Acad Sci"},{"issue":"49","key":"10.1016\/bs.pmbts.2024.04.003_bib138","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1021\/acs.biochem.8b01072","article-title":"Two mutations commonly associated with daptomycin resistance in Enterococcus faecium LiaST120A and LiaRW73C appear to function epistatically in LiaFSR signaling","volume":"57","author":"Davlieva","year":"2018","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.04.003_bib139","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/AAC.01073-15","article-title":"Deletion of liaR reverses daptomycin resistance in Enterococcus faecium independent of the genetic background","volume":"59","author":"Panesso","year":"2015","journal-title":"Antimicrobial Agents Chemother"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib140","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/infdis\/jiu602","article-title":"A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis","volume":"211","author":"Reyes","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib141","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/infdis\/jiz131","article-title":"Disrupting membrane adaptation restores in vivo efficacy of antibiotics against multidrug-resistant Enterococci and potentiates killing by human neutrophils","volume":"220","author":"Rincon","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib142","doi-asserted-by":"crossref","unstructured":"Axell-House D.B., Simar S.R., Panesso D., et al. LiaX is a surrogate marker for cell-envelope stress and daptomycin non-susceptibility in Enterococcus faecium. bioRxiv. Published online August 18, 2023:2023.08.18.553907. https:\/\/doi.org\/10.1101\/2023.08.18.553907.","DOI":"10.1101\/2023.08.18.553907"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib143","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.00021-13","article-title":"A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis","volume":"57","author":"Munita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib144","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1128\/AAC.01473-13","article-title":"Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance","volume":"57","author":"Miller","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"10.1016\/bs.pmbts.2024.04.003_bib145","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1128\/JB.00645-07","article-title":"New insights into the WalK\/WalR (YycG\/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus","volume":"189","author":"Dubrac","year":"2007","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib146","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/JB.01682-07","article-title":"Essentiality, bypass, and targeting of the YycFG (VicRK) two-component regulatory system in Gram-positive bacteria","volume":"190","author":"Winkler","year":"2008","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/bs.pmbts.2024.04.003_bib147","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09168451.2018.1444466","article-title":"Essentiality and function of WalK\/WalR two-component system: the past, present, and future of research","volume":"82","author":"Takada","year":"2018","journal-title":"Biosci Biotechnol Biochem"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib148","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib149","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/AAC.00223-11","article-title":"In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates","volume":"55","author":"Mishra","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002359","article-title":"Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR","volume":"7","author":"Howden","year":"2011","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/bs.pmbts.2024.04.003_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107426","article-title":"Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons","volume":"9","author":"Mishra","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib152","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1128\/AAC.01226-10","article-title":"Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation","volume":"55","author":"Bertsche","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067398","article-title":"Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates","volume":"8","author":"Bertsche","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.04.003_bib154","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1086\/648473","article-title":"Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus","volume":"200","author":"Yang","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2013.10.001","article-title":"dltA overexpression: a strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Cafiso","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib156","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/jac\/dkr195","article-title":"Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach","volume":"66","author":"Fischer","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib157","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02105-18","article-title":"A FASII inhibitor prevents staphylococcal evasion of daptomycin by inhibiting phospholipid decoy production","volume":"63","author":"Pee","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"16","key":"10.1016\/bs.pmbts.2024.04.003_bib158","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1021\/ja4012468","article-title":"Total synthesis of daptomycin by cyclization via a chemoselective serine ligation","volume":"135","author":"Lam","year":"2013","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib159","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/acs.orglett.5b00043","article-title":"Solid-phase total synthesis of daptomycin and analogs","volume":"17","author":"Lohani","year":"2015","journal-title":"Org Lett"},{"issue":"62","key":"10.1016\/bs.pmbts.2024.04.003_bib160","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1002\/chem.201903725","article-title":"A versatile boc solid phase synthesis of daptomycin and analogues using site specific, on\u2010resin ozonolysis to install the kynurenine residue","volume":"25","author":"Xu","year":"2019","journal-title":"Chem Eur J"},{"issue":"14","key":"10.1016\/bs.pmbts.2024.04.003_bib161","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1039\/D0OB02504F","article-title":"A high-yielding solid-phase total synthesis of daptomycin using a Fmoc SPPS stable kynurenine synthon","volume":"19","author":"Moreira","year":"2021","journal-title":"Org Biomol Chem"},{"issue":"8","key":"10.1016\/bs.pmbts.2024.04.003_bib162","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7164\/antibiotics.41.1093","article-title":"Enzymatic and chemical modifications of ipopeptide antibiotic A21978c: the synthesis and evaluation of daptomycin (Ly146032)","volume":"41","author":"Debono","year":"1988","journal-title":"J Antibiot"},{"issue":"23","key":"10.1016\/bs.pmbts.2024.04.003_bib163","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1016\/j.bmcl.2003.07.019","article-title":"Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin","volume":"13","author":"Hill","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"23","key":"10.1016\/bs.pmbts.2024.04.003_bib164","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1016\/j.bmcl.2003.07.025","article-title":"Array synthesis of novel lipodepsipeptide","volume":"13","author":"Siedlecki","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"19","key":"10.1016\/bs.pmbts.2024.04.003_bib165","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1016\/j.bmcl.2012.08.013","article-title":"Reduced pulmonary surfactant interaction of daptomycin analogs via tryptophan replacement with alternative amino acids","volume":"22","author":"He","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib166","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nchembio.2285","article-title":"Structure and specificity of a permissive bacterial C-prenyltransferase","volume":"13","author":"Elshahawi","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"18","key":"10.1016\/bs.pmbts.2024.04.003_bib167","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1007\/s00253-020-10790-x","article-title":"Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains","volume":"104","author":"Scull","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.04.003_bib168","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1002\/chem.202005100","article-title":"Regiospecific synthesis of calcium\u2010independent daptomycin antibiotics using a chemoenzymatic method","volume":"27","author":"Mupparapu","year":"2021","journal-title":"Chem Eur J"},{"key":"10.1016\/bs.pmbts.2024.04.003_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115638","article-title":"A facile and selective derivatization approach on kynurenine-NH2 in daptomycin, leading to the discovery of hexakynomycin to combat multidrug-resistant Gram-positive pathogens especially daptomycin-resistant bacteria","volume":"259","author":"Guan","year":"2023","journal-title":"Eur J Medicinal Chem"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib170","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/bi036140d","article-title":"Chemo- and regioselective peptide cyclization triggered by the N-terminal fatty acid chain length: the recombinant cyclase of the calcium-dependent antibiotic from Streptomyces coelicolor\u2020","volume":"43","author":"Gr\u00fcnewald","year":"2004","journal-title":"Biochemistry"},{"issue":"35","key":"10.1016\/bs.pmbts.2024.04.003_bib171","doi-asserted-by":"crossref","first-page":"10474","DOI":"10.1021\/bi0609422","article-title":"Chemoenzymatic design of acidic lipopeptide hybrids: new insights into the structure\u2212activity relationship of daptomycin and A54145","volume":"45","author":"Kopp","year":"2006","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.04.003_bib172","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1021\/acs.jmedchem.5b00366","article-title":"Structure\u2013activity relationship studies of a series of semisynthetic lipopeptides leading to the discovery of surotomycin, a novel cyclic lipopeptide being developed for the treatment of Clostridium difficile-associated diarrhea","volume":"58","author":"Yin","year":"2015","journal-title":"J Med Chem"},{"issue":"2\u20133","key":"10.1016\/bs.pmbts.2024.04.003_bib173","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10295-015-1714-6","article-title":"Discovery and development of surotomycin for the treatment of Clostridium difficile","volume":"43","author":"Knight-Connoni","year":"2016","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib174","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ja.2010.138","article-title":"Production of novel lipopeptide antibiotics related to A54145 by Streptomyces fradiae mutants blocked in biosynthesis of modified amino acids and assignment of lptJ, lptK and lptL gene functions","volume":"64","author":"Alexander","year":"2011","journal-title":"J Antibiot"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib175","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1039\/C3OB42238K","article-title":"A combined solid- and solution-phase approach provides convenient access to analogues of the calcium-dependent lipopeptide antibiotics","volume":"12","author":"Hart","year":"2014","journal-title":"Org Biomol Chem"},{"issue":"23","key":"10.1016\/bs.pmbts.2024.04.003_bib176","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1016\/j.bmcl.2015.10.072","article-title":"Solid-phase synthesis and in vitro biological activity of a Thr4\u2192Ser4 analog of daptomycin","volume":"25","author":"Lohani","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/bs.pmbts.2024.04.003_bib177","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bmc.2018.12.004","article-title":"The effect of replacing the ester bond with an amide bond and of overall stereochemistry on the activity of daptomycin","volume":"27","author":"Moreira","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"10.1016\/bs.pmbts.2024.04.003_bib178","doi-asserted-by":"crossref","first-page":"e3430","DOI":"10.1002\/psc.3430","article-title":"Studies on daptomycin lactam-based analogues","volume":"28","author":"Chow","year":"2022","journal-title":"J Pept Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib179","doi-asserted-by":"crossref","first-page":"e24255","DOI":"10.1002\/pep2.24255","article-title":"Synthesis of a daptomycin thiolactone analogue via the MeDbz-linker-based cyclative-cleavage approach","volume":"114","author":"Cheung","year":"2022","journal-title":"Peptide Sci"},{"issue":"46","key":"10.1016\/bs.pmbts.2024.04.003_bib180","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0608589103","article-title":"Combinatorial biosynthesis of novel antibiotics related to daptomycin","volume":"103","author":"Nguyen","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2024.04.003_bib181","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/acsinfecdis.1c00483","article-title":"Discovery of highly active derivatives of daptomycin by assessing the effect of amino acid substitutions at positions 8 and 11 on a daptomycin analogue","volume":"8","author":"Barnawi","year":"2022","journal-title":"ACS Infect Dis"},{"issue":"3","key":"10.1016\/bs.pmbts.2024.04.003_bib182","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bmcl.2016.12.046","article-title":"Structure-activity relationship of daptomycin analogues with substitution at (2S, 3R) 3-methyl glutamic acid position","volume":"27","author":"Lin","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib183","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/acs.jmedchem.9b01957","article-title":"Methylation of daptomycin leading to the discovery of kynomycin, a cyclic lipodepsipeptide active against resistant pathogens","volume":"63","author":"Chow","year":"2020","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/bs.pmbts.2024.04.003_bib184","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1021\/acs.jmedchem.7b00102","article-title":"Targeted antibiotic delivery: selective siderophore conjugation with daptomycin confers potent activity against multidrug resistant Acinetobacter baumannii both in vitro and in vivo","volume":"60","author":"Ghosh","year":"2017","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/bs.pmbts.2024.04.003_bib185","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1021\/acsinfecdis.8b00150","article-title":"Siderophore conjugates of daptomycin are potent inhibitors of carbapenem resistant strains of Acinetobacter baumannii","volume":"4","author":"Ghosh","year":"2018","journal-title":"ACS Infect Dis"},{"issue":"6","key":"10.1016\/bs.pmbts.2024.04.003_bib186","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00726-020-02868-7","article-title":"Highly efficient and enantioselective syntheses of (2S,3R)-3-alkyl- and alkenylglutamates from Fmoc-protected Garner\u2019s aldehyde","volume":"52","author":"Moreira","year":"2020","journal-title":"Amino Acids"}],"container-title":["Progress in Molecular Biology and Translational Science","Protein and Peptide Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T05:21:42Z","timestamp":1742620902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117324000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443235306"],"references-count":186,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2024.04.003","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}